Advanced Oncotherapy is an innovative technology business focused on delivering proton-based radiotherapy system using technology originally developed and tested at the world- renowned CERN facility in Switzerland.
Proton beam therapy is likely to play a crucial role in the affordable treatment of cancer in the future. Advanced Oncotherapy’s system is based on a linear accelerator (‘LIGHT’) technology that is superior to traditional cyclotron/synchrotron accelerators and significantly less expensive to implement than its competitors. The company acquired the technology through the acquisition of ADAM, a CERN spin-off company, in 2013.
Advanced Oncotherapy’s head office is in London, with R&D/ADAM located on the CERN campus in Switzerland, and a manufacturing plant, clinical research and clinician training facility in Syracuse, USA.
See our webiste: http://www.advancedoncotherapy.com/